Cancer diagnostics firm bio Genome Diagnostics ( PGDx ) has raised $ 65 million in an open equity financing round . It aims to raise a total of $ 200 m in the round . PGDx offers cancer patients clinical analysis to provide better diagnosis and treatments . Thus far , 12 investors have purchased equity . PGDx already gained $ 21.4 m in a round A funding round in 2015 , adding to its previous $ 2.8 m in seed funding .
Cancer diagnostics firm Personal Genome Diagnostics (PGDx) has raised $65m in an open equity financing round. It aims to raise a total of $111.5m in the round. PGDx offers cancer patients gene analysis to provide better diagnoses and treatments. Thus far, 12 investors have purchased equity. PGDx already gained $21.4m in a series A funding round in 2015, adding to its previous $2.8m in seed funding.